OCSL OAKTREE SPECIALT

Ownership history in MARSHALL WACE, LLP  ·  7 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in OAKTREE SPECIALT (OCSL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q1)
Avg. % of fund
0.01%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 54,148 +36,137 +200.6% 0.00% $707K $12.21
2025 Q2 REDUCED 18,011 -59,417 -76.7% 0.00% $246K $12.41
2024 Q4 REDUCED 77,428 -162,059 -67.7% 0.00% $1.2M $13.07
2024 Q3 REDUCED 239,487 -247,008 -50.8% 0.00% $3.9M $13.48
2024 Q2 REDUCED 486,495 -79,009 -14.0% 0.01% $9.2M $15.02
2024 Q1 ADDED 565,504 +453,217 +403.6% 0.02% $11.1M $15.26
2023 Q4 INITIATED 112,287 0.00% $2.3M
% of Fund (quarterly)    OCSL price (monthly, adj. close)
← Back to MARSHALL WACE, LLP Holdings